Volume 10, Number 8—August 2004
Rickettsia parkeri in Amblyomma triste from Uruguay
Highlight and copy the desired format.
|EID||Venzal JM, Portillo A, Estrada-Peña A, Castro O, Cabrera PA, Oteo JA, et al. Rickettsia parkeri in Amblyomma triste from Uruguay. Emerg Infect Dis. 2004;10(8):1493-1495. https://dx.doi.org/10.3201/eid1008.030999|
|AMA||Venzal JM, Portillo A, Estrada-Peña A, et al. Rickettsia parkeri in Amblyomma triste from Uruguay. Emerging Infectious Diseases. 2004;10(8):1493-1495. doi:10.3201/eid1008.030999.|
|APA||Venzal, J. M., Portillo, A., Estrada-Peña, A., Castro, O., Cabrera, P. A., & Oteo, J. A. (2004). Rickettsia parkeri in Amblyomma triste from Uruguay. Emerging Infectious Diseases, 10(8), 1493-1495. https://dx.doi.org/10.3201/eid1008.030999.|
Our goal was to detect whether spotted fever group Rickettsia are found in the suspected vector of rickettsioses, Amblyomma triste, in Uruguay. Rickettsia parkeri was detected in A. triste, which suggests that this species could be considered a pathogenic agent responsible for human rickettsioses in Uruguay.
In South America, cases of rickettsioses produced by the genus Rickettsia have been described in several countries in the last 20 years. The first three native cases of rickettsioses in Uruguay were reported in 1990. Patients had an initial small necrotic lesion (eschar) on the tick-bite point of attachment, fever and regional lymphadenopathies, an erythematous maculopapular rash, or any combination of these symptoms. Ticks involved in these cases were classified as Amblyomma triste (1), formerly thought to be A. maculatum (2).
A. triste is a neotropical tick species with a variety of hosts (3,4). It is the main tick species feeding on humans in Uruguay, and it is the primary candidate vector for transmitting rickettsioses in this country (5). According to the literature (2), Rickettsia conorii has been the causative agent of rickettsial diseases in Uruguay, but the evidence has been only serologic (by antirickettsial microimmunofluorescence testing) in all patients with suspected rickettsioses (6,7). Neither rickettsial isolation nor polymerase chain reaction (PCR) amplification from human blood samples from patients from Uruguay have been performed. However, as has been suggested (8), other tick-transmitted rickettsiae could be present in Uruguay.
The aim of this study was to identify the spotted fever group (SFG) rickettsial species present in the suspected vector of SFG rickettsioses in Uruguay (A. triste). From 1999 to 2004, in Uruguay, ticks were collected from humans (with and without rickettsial syndrome), other mammals, and vegetation and preserved in ethanol 70% at room temperature. Species, sex, and stage of development were determined by members of the Facultad de Veterinaria, Universidad de la República (Uruguay). Classified adult ticks (N = 91) were sent to the Hospital de La Rioja (Spain) for analysis with molecular biologic techniques. Thirty-six ticks recovered from 14 humans were attached but nonengorged. Only one tick removed from a human, the one corresponding to patient 3, was attached and engorged. A total of 16 A. triste were captured walking on three different humans (nonattached). The remaining ticks were attached to two goats (n = 3), a rodent of the species Scapteromys tumidus (n = 4), and three dogs (n = 30; 19 of them were engorged). One tick was recovered from vegetation. Details are shown in the Table.
DNA from the ticks was extracted by using the Tissue DNA Spin Kit (Genomed, Granada, Spain) according to the manufacturer’s instructions. PCR testing for ompA, gltA, and 16S rRNA genes was performed as previously described (9–11). Two negative controls (one of them with template DNA but without primers and the other with primers and containing water instead of template DNA) as well as a positive control (R. conorii Malish #7 grown in Vero cells) were included in all PCR assays. Restriction analysis of ompA amplicons was also carried out under conditions reported by Roux et al. (12). Each PCR-amplified fragment of ompA gene was sequenced twice for all positive samples (Universidad de Alcalá de Henares, Spain) to confirm the identification of rickettsiae. Data were aligned with homologous sequences of reference strains of the SFG rickettsiae retrieved from the GenBank database.
Six ticks (three females and three males) collected on three people and three dogs yielded positive PCR products of the expected sizes for ompA, gltA, and 16S rRNA, respectively (Table). One of these ticks infected with SFG Rickettsia (the only one that was engorged) was removed from a woman (patient 3) diagnosed with rickettsial syndrome in the Instituto de Higiene, Facultad de Medicina, Universidad de la República (Uruguay). This patient showed a small initial maculopapulous lesion on her scalp at the tick-bite point, followed by regional lymphadenopathies and fever. Diagnosis was made on the basis of the clinical picture and indirect immunoglobulin (Ig) G immunofluorescent technique with R. conorii antigen (Biomerieux Laboratories, Marcy l’Etiole, France). Serum specimens were collected during the acute phase (day 0) and convalescent phase (1 month later). The patient showed seroconversion for R. conorii with IgG, and she had a benign disease course after treatment with oral tetracyclines. No clinical signs of infection were confirmed for the remaining two humans bitten by ticks infected with SFG Rickettsia (humans 6 and 7), but ticks were removed immediately after attachment in these cases. For all six positive samples, sequence analysis for ompA amplicons showed 100% similarity with the homologous sequence of R. parkeri (GenBank accession no. U43802). Profiles obtained with RsaI for ompA PCR fragments were also in accordance with these data.
SFG Rickettsia isolated from arthropods and initially classified as nonpathogenic to humans are increasingly recognized as causing emerging rickettsial diseases (13). In the last 10 years, different Rickettsia species and subspecies, such as R. aeschlimannii (14), R. sibirica strain mongolotimonae (15), and R. slovaca (16), among others, have been implicated as human pathogens. Very recently, a new tickborne Rickettsia, R. parkeri, has been identified as a cause of human disease in the southern United States (17). According to Paddock et al., R. parkeri rickettsioses may also occur in other regions of the Western Hemisphere, e.g., in Uruguay.
We report R. parkeri infection in A. triste ticks collected in Uruguay. Several cases of rickettsioses have been described in this country but, to date, no Rickettsia has been isolated, cultivated, and characterized as the causative agent. A few years ago, R. conorii was presumptively considered the etiologic agent, but diagnosis was established with serologic assays (indirect microimmunofluorescence testing) as reference technique (6). Cross-reactions are noted within SFG Rickettsia antigens, and available serologic tests cannot be used to implicate a specific pathogen. In Uruguay, A. triste frequently bites people, and rickettsioses frequently develop in these people (5). Our finding of R. parkeri infection in one A. triste tick collected from a patient with rickettsiosis suggests that R. parkeri could be a pathogenic SFG Rickettsia involved in rickettsial diseases in Uruguay. Traditionally, this agent was reported as nonpathogenic to humans, but the first report of a human infection with R. parkeri was recently published (17). It has also recently shown to be mildly pathogenic to guinea pigs (18). In our study, R. parkeri was the only detected SFG Rickettsia in A. triste ticks from Uruguay. Our data suggest that A. triste is a host of SFG Rickettsia in Uruguay, and R. parkeri could be the causative agent of human cases of rickettsioses in Uruguay.
Dr. Venzal is a researcher in the Veterinary Parasitology Department at Universidad de La República, Montevideo, Uruguay. His research interests include ticks (Ixodida) and the epidemiology of tickborne diseases.
We thank Fátima Bacellar for supplying SFG Rickettsia–positive controls and Elena Zanetta for providing clinical data.
This study was partly supported by grants from the Fondo de Investigación Sanitaria (FIS PI021810 y FIS G03/057) from the Ministerio de Sanidad y Consumo, Spain.
- Venzal JM, Cabrera P, de Souza C, Fregueiro C. Las garrapatas del género Ixodes (Acari: Ixodidae) en Uruguay: su relación con la fauna silvestre y acción como potenciales transmisores de enfermedades. In: Jornadas sobre animales silvestres, desarrollo sustentable y medio ambiente. Montevideo: Facultad de Veterinaria; 2000. p. 55–7.
- Conti-Díaz IA, Rubio I, Somma Moreira RE, Pérez Bormida G. Lymphatic cutaneous rickettsioses caused by Rickettsia conorii in Uruguay. Rev Inst Med Trop Sao Paulo. 1990;32:313–8.
- Venzal JM, Castro O, Cabrera PA, de Souza CG, Guglielmone AA. Las garrapatas de Uruguay: especies, hospedadores, distribución e importancia sanitaria. Veterinaria (Montevideo). 2003;38:17–28.
- Venzal JM, González EM, Capellino D, Estrada Peña A, Guglielmone AA. First record of Amblyomma triste Koch, 1844 (Acari: Ixodidae) and new records of Ornithodoros mimon Kohls, Clifford & Jones, 1969 (Acari: Argasidae) from neotropical bats. Syst Appl Acarol. 2003;8:93–6.
- Venzal JM, Guglielmone AA, Estrada Peña A, Cabrera PA, Castro O. Ticks (Ixodidae) parasitising humans in Uruguay. Ann Trop Med Parasitol. 2003;97:769–72.
- Pedreira W, Mazini A, Di Lorenzo S, Medrano O. Fiebre botonosa del Mediterráneo. Primer foco endémico en las Américas. In: Libro de resúmenes: Congreso Interamericano de Infectología 1. Córdoba: Sociedad de Infectología de Córdoba; 1994. p. 220.
- Conti-Díaz IA. Rickettsiosis por Rickettsia conorii (fiebre botonosa del Mediterráneo o fiebre de Marsella). Estado actual en Uruguay. Rev Méd Uruguay. 2001;17:119–24.
- Conti-Díaz IA. Rickettsiosis caused by Rickettsia conorii in Uruguay. Ann N Y Acad Sci. 2003;990:264–6.
- Regnery RL, Spruill CL, Plikaytis BD. Genotypic identification of rickettsiae and estimation of intraspecies sequence divergence for portions of two rickettsial genes. J Bacteriol. 1991;173:1576–89.
- Weisburg WG, Dobson ME, Samuel JE, Dasch GA, Mallavia LP, Baca O, Phylogenetic diversity of the rickettsiae. J Bacteriol. 1989;171:4202–6.
- Márquez FJ, Muniain MA, Soriguer RC, Izquierdo G, Rodríguez-Baño J, Borobio MV. Genotypic identification of an undescribed spotted fever group Rickettsia in Ixodes ricinus from Southwest Spain. Am J Trop Med Hyg. 1998;58:570–7.
- Roux V, Fournier P, Raoult D. Differentiation of spotted fever group rickettsiae by sequencing and analysis of restriction fragment length polymorphism of PCR amplified DNA of the gene encoding the protein rOmpA. J Clin Microbiol. 1996;34:2058–65.
- Raoult D. A new rickettsial disease in the United States. Clin Infect Dis. 2004;38:812–3.
- Raoult D, Fournier PE, Abboud P, Caron F. First documented human Rickettsia aeschlimanii infection. Emerg Infect Dis. 2002;8:748–9.
- Fournier PE, Tissot-Dupont H, Gallais H, Raoult D. Rickettsia mongolotimonae: a rare pathogen in France. Emerg Infect Dis. 2000;6:290–2.
- Raoult D, Berbis P, Roux V, Xu W, Maurin M. A new tick-transmitted disease due to Rickettsia slovaca. Lancet. 1997;350:112–3.
- Paddock CD, Sumner JW, Comer JA, Zaki SR, Goldsmith CS, Goddard J, Rickettsia parkeri: a newly recognized cause of spotted fever rickettsiosis in the United States. Clin Infect Dis. 2004;38:805–11.
- Goddard J. Experimental infection of lone star ticks, Amblyomma americanum (L.), with Rickettsia parkeri and exposure of guinea pigs to the agent. J Med Entomol. 2003;40:686–9.
TableCite This Article
Please use the form below to submit correspondence to the authors or contact them at the following address:
José M. Venzal, Departamento de Parasitología Veterinaria, Facultad de Veterinaria, Universidad de la República, Av. Alberto Lasplaces, 1550, 11600- Montevideo, Uruguay; fax: 00-598-26280130
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: March 01, 2011
- Page last updated: March 01, 2011
- Page last reviewed: March 01, 2011
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)